[144] ARGAN INC SEC Filing

Rhea-AI Filing Summary

ARGAN, Inc. (AGX) submitted a Form 144 notice disclosing a proposed sale of 13,444 shares of common stock through Allen & Company on the NYSE with an aggregate market value of $3,667,792.08. The filing lists total shares outstanding of 13,811,575 and an approximate sale date of 09/30/2025. The securities reported were acquired via equity grants and restricted stock on 06/21/2023 (5,000 shares), 06/14/2024 (5,852 shares) and 12/14/2024 (2,592 shares). The document also reports recent sales by James W. Quinn: 11,897 shares on 09/19/2025 for $3,101,904.81 and 4,660 shares on 09/22/2025 for $1,208,571. The filer affirms no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider proposes a modest sale disclosed under Rule 144; documentation shows acquisition history and recent disposition amounts.

The Form 144 details a proposed sale of 13,444 shares with an aggregate value of $3.67 million, executed through a recognized broker on the NYSE. The filing transparently traces acquisition sources to equity grants and a restricted stock issuance, which is important for assessing resale eligibility under Rule 144. Reported recent sales by James W. Quinn provide concrete execution context, showing proceeds and dates. From a securities perspective this is a routine compliant disclosure rather than a company-operational filing; it provides necessary market and compliance information but does not contain operational or financial performance metrics.

Corporate Governance Expert

TL;DR: The notice is a standard insider sale disclosure that supports governance transparency but reveals no governance changes.

The Form 144 affirms the seller represents no undisclosed material adverse information and documents the origin of shares sold (equity grants, option exercise, restricted stock). That traceability supports corporate governance best practices for insider transactions. The filing does not indicate departures, plan adoptions, or governance actions; it solely records proposed sales and recent executed transactions, which assists investors in monitoring insider liquidity events without implying board or management shifts.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Allen & Company 711 Fifth Avenue New York NY 10022	13444	3667792.08	13811575	09/30/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/21/2023	EQUITY GRANT	ISSUER			5000	06/21/2023	OPTION EXERCISE
Common Stock	06/14/2024	EQUITY GRANT	ISSUER			5852	06/14/2024	OPTION EXERCISE
Common Stock	12/14/2024	TIME-BASED RESTRICTED STOCK ISSUANCE	ISSUER			2592	12/14/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James W. Quinn 711 Fifth Avenue New York NY 10022	Common Stock	09/19/2025	11897	3101904.81
James W. Quinn 711 Fifth Avenue New York NY 10022	Common Stock	09/22/2025	4660	1208571

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AGX Form 144 disclose about the number of shares to be sold?

The filing discloses a proposed sale of 13,444 shares of common stock.

What is the aggregate market value of the proposed AGX sale?

The aggregate market value reported is $3,667,792.08.

When is the approximate date of the proposed sale listed on the Form 144?

The approximate date of sale is listed as 09/30/2025.

How were the securities being sold by the AGX filer originally acquired?

The securities were acquired via equity grants, option exercise, and a time-based restricted stock issuance on the dates provided in the filing.

What recent sales by the same person are disclosed in the filing?

The filing reports James W. Quinn sold 11,897 shares on 09/19/2025 for $3,101,904.81 and 4,660 shares on 09/22/2025 for $1,208,571.